Federal contractor · GAITHERSBURG, MD

DEXORGEN INC.

DEXORGEN INC. received -$24.8K in federal contract obligations in FY2026, on 1 awards. Since FY2017: $2.3M. Its largest customer was National Institutes of Health (-$24.8K).

Obligations · FY2026
-$24.8K
New awards
1
Sole-source
—
Single offer
—
UEI
ZNUMJ4FKRC19
Small businessMinority-owned
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 224.7KFY2017
  2. 610.7KFY2018
  3. 1MFY2019
  4. 40KFY2020
  5. 91.6KFY2021
  6. 78.4KFY2022
  7. 116.4KFY2023
  8. 79.2KFY2024
  9. -30FY2025
  10. -24.8KFY2026

Top buying agencies

Obligations in FY2026.

  1. National Institutes of Health-$24.8K0.0%
    1 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Where the work was performed

Integrity signals

Shares of the year's obligations, next to the country's.

Largest awards

  1. CELL LINE CONSTRUCTION FOR GPCR RECEPTOR SCREENING$0
    National Institutes of Health· Montgomery County, MD· Health & medical· Sep 3, 2021 – Feb 6, 2026· 75N93021P01316

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 3 markets (agency × industry), FY2024–FY2026.

  1. JACKSON LABORATORY$11.4M+165% in FY2026
    BAR HARBOR, ME · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Architectural, engineering, and related servicesNational Institutes of Health · Other professional, scientific, and technical servicesNational Institutes of Health · Pharmaceutical and medicine manufacturing
  2. QIAGEN, LLC$17.9M−19% in FY2026
    GERMANTOWN, MD · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Architectural, engineering, and related servicesNational Institutes of Health · Other professional, scientific, and technical servicesNational Institutes of Health · Pharmaceutical and medicine manufacturing
  3. CHARLES RIVER LABORATORIES, INC.$188.8M−24% in FY2026
    WILMINGTON, MA · 3 entities · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Architectural, engineering, and related servicesNational Institutes of Health · Other professional, scientific, and technical servicesNational Institutes of Health · Pharmaceutical and medicine manufacturing

Showing the top 3 of 4 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026.